Rybelsus®

Rybelsus
Manufacturer: Novo Nordisk India Pvt Ltd

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.

3mg

Package Savings Per tablet Price Order
90 tablets QAR 1651.56 QAR 55.10 QAR 4958.91
  • Free AirMail shipping
60 tablets QAR 880.70 QAR 58.77 QAR 3526.28
  • Free AirMail shipping
30 tablets QAR 330.24 QAR 62.44 QAR 1873.25
  • Free AirMail shipping
20 tablets QAR 146.75 QAR 66.11 QAR 1322.24
  • Free AirMail shipping
10 tablets QAR 73.45 QAR 734.50
  • Free AirMail shipping

7mg

Package Savings Per tablet Price Order
90 tablets QAR 659.74 QAR 66.12 QAR 5950.72
  • Free AirMail shipping
60 tablets QAR 329.69 QAR 67.95 QAR 4077.29
  • Free AirMail shipping
30 tablets QAR 109.83 QAR 69.79 QAR 2093.65
  • Free AirMail shipping
20 tablets QAR 36.55 QAR 71.62 QAR 1432.44
  • Free AirMail shipping
10 tablets QAR 73.45 QAR 734.50
  • Free AirMail shipping

14mg

Package Savings Per tablet Price Order
90 tablets QAR 825.05 QAR 78.98 QAR 7107.85
  • Free AirMail shipping
60 tablets QAR 439.89 QAR 80.81 QAR 4848.70
  • Free AirMail shipping
30 tablets QAR 164.94 QAR 82.65 QAR 2479.36
  • Free AirMail shipping
20 tablets QAR 73.28 QAR 84.48 QAR 1689.58
  • Free AirMail shipping
10 tablets QAR 88.14 QAR 881.43
  • Free AirMail shipping

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.